Moreover, further investigations show that cGAMP-siPDL1@GalNPs + L yielded the highest rates of IFN-γ+CD8+ and granzyme B–secreting CD8+ T cells (granzyme B+CD8+) in the melanoma TME than the other treatments (Fig. 6, D and E, and fig. This evidence concerns the gene CD8A and melanoma.